Skip to main content
Anbio Biotechnology (NNNN)
NASDAQ: NNNN · Real-Time Price · USD
22.21
-0.68 (-2.97%)
At close: Mar 9, 2026, 4:00 PM EDT
22.20
-0.01 (-0.05%)
After-hours: Mar 9, 2026, 6:05 PM EDT

Anbio Biotechnology Revenue

Anbio Biotechnology had revenue of $4.58M in the half year ending June 30, 2025, with 49.85% growth. This brings the company's revenue in the last twelve months to $6.92M, down -27.17% year-over-year. In the year 2024, Anbio Biotechnology had annual revenue of $8.19M with 21.95% growth.

Revenue (ttm)
$6.92M
Revenue Growth
-27.17%
P/S Ratio
140.87
Revenue / Employee
$256,302
Employees
27
Market Cap
974.82M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20248.19M1.47M21.95%
Dec 31, 20236.71M-16.83M-71.49%
Dec 31, 202223.54M19.12M431.67%
Dec 31, 20214.43M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

NNNN News

More News